- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Datametrex Subsidiary Canntop AI Focuses on Cannabis
Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased to announce that its newly formed subsidiary, Canntop AI Inc. (“Canntop AI”), will leverage Nexalogy’s strong experience working on AI solutions for the vaping sector.
Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV:DM, FSE:D4G) is pleased to announce that its newly formed subsidiary, Canntop AI Inc. (“Canntop AI”), will leverage Nexalogy’s strong experience working on AI solutions for the vaping sector. Canntop AI will continue to use Nexalogy’s technology to become a leading provider of social data analysis in the Cannabis space.
Nexalogy has a multi-year track record of successfully working with various Canadian federal agencies including Health Canada. One of the programs Nexalogy has worked on with Health Canada was focused on the vaping industry. Nexalogy’s technology targeted key trends and social discovery, allowing Health Canada to have deeper insight into usage and patterns. As a proven solution provider to the Federal Government, we believe that we are well positioned to bid on new projects providing social data insights to multiple agencies. The Cannabis sector is expected to grow significantly, generating massive amounts of social data that will need to be collected, scrubbed and analyzed.
We created Canntop AI to focus on the Cannabis sector as we have seen the positive results of our solutions and work in the vaping area and anticipate that the Cannabis space will benefit strongly from our technology. Canntop AI will focus on the Cannabis market, including insight and analytical data on cosmetics, CBD, recreational and medical use, as well as consumables.
“This is a tremendous opportunity for Datametrex to build on existing relationships and previous contracts with various Government Agencies. We believe there will be tremendous demand by various groups for clear, concise and actionable social data analysis surrounding the Cannabis sector. Creating Canntop AI demonstrates our commitment to becoming a global leader in this marketplace,” says Andrew Ryu, CEO and Chairman of the Company.
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to four exciting verticals. Big data, Artificial intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Implementing Blockchain technology for secure data transfers through its joint venture company, Graph Blockchain Limited (www.graphblockchain.com). Industrial scale cryptocurrency mining through its wholly owned subsidiary, Ronin Blockchain Corp. (www.roninblockchain.com).
Additional information on Datametrex is available at: www.datametrex.com
To stay informed about Datametrex, please join our Investor Group on 8020 Connect https://bit.ly/2fPUNwF for all upcoming news releases, articles comments and questions.
For further information, please contact:
Jeffrey Stevens – President & COO
Phone: (647) 400-8494
Email: jstevens@datametrex.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Forward-looking information is not a guarantee of future performance or results, since it involves risks and uncertainties. There is no assurance that forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in forward-looking statements. Except as required by law, the Company does not assume and expressly renounces any obligation to update any forward-looking information, which is only applicable on the date on which it is given.
Source: globenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.